Literature DB >> 21394301

Tumor margin histology predicts tumor aggressiveness in papillary thyroid carcinoma: a study of 514 consecutive patients.

Kuk-Jin Kim1, Soon Won Hong, Yong Sang Lee, Bup-Woo Kim, Seung Chul Lee, Hang-Seok Chang, Cheong Soo Park.   

Abstract

Histologic patterns at tumor margins may be related to prognosis in several malignancies. We investigated tumor aggressiveness with respect to tumor margin histology in patients with papillary thyroid carcinoma (PTC). Five hundred fourteen consecutive patients who underwent surgery for primary PTC between January and July 2009 were assigned to two groups, one with an infiltrative pattern (I-type, n = 347) at tumor margins and one with an expanding pattern (E-type, n = 167). Tumor aggressiveness was assessed by analyzing relationships between these patterns and known prognostic factors. The analysis showed that unfavorable prognostic factors such as tumor multiplicity (P = 0.002), extrathyroidal extension (P < 0.001), lateral neck lymph node metastasis (P < 0.001) and advanced TNM stage (P = 0.001) were significantly more prevalent in patients with I-type PTC than in those with the E-type. Central neck node metastases were more prevalent without statistical significance in the I-type patients (P = 0.376). Tumor margin histology was not related to gender or tumor size. These results suggest that histologic patterns at tumor margins predict aggressiveness in PTC.

Entities:  

Keywords:  Aggressiveness; Carcinoma, Papillary; Histology; Margin; Thyroid

Mesh:

Year:  2011        PMID: 21394301      PMCID: PMC3051080          DOI: 10.3346/jkms.2011.26.3.346

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


INTRODUCTION

Incidence of thyroid cancer is rapidly increasing in Korea (1). Papillary thyroid carcinoma (PTC) is the most common malignancy of the thyroid and most PTCs display relatively low aggressiveness and have a favorable prognosis. Prognostic factors in PTC include age, tumor size, extrathyroidal extension, lymph node metastases, and distant metastases (2-4). Tumor multiplicity and coexisting lymphocytic thyroiditis may also influence the prognosis (5-11), and some PTC variants show characteristic behaviors. Warthin-like variants, for instance, have a favorable prognosis, while tall cell and columnar variants have a less favorable prognosis than typical PTCs (12-15). Histologic patterns of growth into surrounding stroma characterize the margins of primary tumors as expanding (pushing) or infiltrative (invasive). To our knowledge, however, the prognostic significance of tumor margin histology in patients with PTC has not been determined. For this purpose, we assessed PTC aggressiveness from relationships between growth patterns at tumor margins and factors known to influence the prognosis of PTC patients.

MATERIALS AND METHODS

Patients

Of the 762 patients who underwent surgery for thyroid cancer at Thyroid Cancer Center, Gangnam Severance Hospital, Yonsei University College of Medicine, between January and July 2009, we enrolled 514 (67.5%) for this study. Patients with recurrent or persistent PTC, those who underwent less than total thyroidectomy were excluded. During histological review, patients with specific PTC variants (follicular, diffuse sclerosing, columnar variants, etc.) or encapsulated PTCs were also excluded; therefore only classical papillary carcinoma patients were enrolled in study. While central compartment node dissections were performed prophylactically, lateral neck dissections were performed in patients with clinically proven lateral node metastases. Medical records and pathology reports of patients were retrospectively reviewed.

Histologic classification of tumor margins and clinicopathologic features

The histology of tumor margins were reviewed by an experienced endocrine pathologist. Microscopic examinations were performed using formalin-fixed, paraffin embedded tissue sections routinely hematoxylin-eosin stained and assessed at a × 40 and 100 magnification. Tumor margin was defined as the 'transition zone' between the periphery of tumor and normal thyroid stroma. When the features of tumor margin met the following conditions that 1) well-circumscribed and smooth-pushing border around whole tumor, 2) continuous tumor contour with no pointed portion, and 3) tumor invading normal stroma with broad front, they were classified into E-type (expanding type) (Fig. 1). Whereas, the tumor margins that contained the features like 1) uneven and irregular shaped border, 2) presence of spiculated/pointed portion(s) around tumor, and 3) penetration or dissection of normal stroma by tumor cells were classified into I-type (infiltrative type) (Fig. 2). All 514 PTC patients were classified into one of these two groups.
Fig. 1

Papillary thyroid carcinoma (PTC) with expanding margins (E-type). (A, C, D) PTCs show pushing growth pattern (arrows). No infiltrative portions are identified. (B) Magnification of the squared portion in A (H&E, Magnifications: A and C, × 40; B and D, × 100).

Fig. 2

Papillary thyroid carcinomas (PTC) with infiltrative margins (I-type). (A, B) PTC with extrathyroidal extension (arrowhead). Infiltrative growths into surrounding normal parenchyma are identified (arrows). (C, D) PTC show diffuse, infiltrative margin between tumor and normal parenchyma (arrows). (H&E, Magnifications: A and C, × 40; B and D, × 100).

Risk factors, including patient age and gender, size of the primary tumor, tumor multiplicity, extrathyroidal extension, coexistence of lymphocytic thyroiditis, and metastasis to central and/or lateral neck lymph nodes, were compared between patients with E-type margins and those with the I-type. This comparison was also performed for patients with papillary thyroid microcarcinoma (PTMC) (primary tumor size ≤ 1 cm). The distribution of margin types in relation to TNM stage was also evaluated (4).

Statistical analysis

The independent t-test, the Mann-Whitney U test and the chesquare test were used to compare clinicopathologic features between patients with the two margin types. A P value < 0.05 was considered statistically significant.

Ethics statement

The Institutional Review Board of Gangnam Severance Hospital, Yonsei University College of Medicine approved this study protocol (3-20090128). Waiver of informed consent was approved.

RESULTS

Mean age of the patients was 47.6 yr (47.6 ± 11.2) and the male to female ratio was 1:5.2 (83:431). There were 167 patients with E-type margins and 347 with I-type margins. All patients underwent total thyroidectomy with central neck node dissection. In addition, 64 patients underwent lateral neck dissection, including 58 patients with unilateral and 6 with bilateral neck dissection. No patients showed distant metastases in preoperative evaluation. The mean age of patients with I-type PTCs was significantly lower than that of patients with E-type tumors (P = 0.009). Table 1 summarizes the relationships between the types of tumor margin and various clinicopathologic factors. The I-type margin was associated with significantly higher rates of tumor multiplicity (P = 0.002), extrathyroidal extension (P < 0.001), coexistence of lymphocytic thyroiditis (P = 0.011), and metastasis to lateral neck lymph nodes (P < 0.001) than the E-type. The rate of metastasis to central neck lymph nodes was also higher among patients with I-type than with E-type (41.2% vs 37.1%), but the difference was not significant.
Table 1

Relationships between tumor margin type and clinicopathologic factors (N = 514)

*Analysis among the patients aged 45 yr or older (n = 315); NS, not significant.

Among the 315 patients aged 45 yr or older, we found a significant correlation between advanced stage and I-type margins (P < 0.001) (Table 1). Particularly, all of the 13 patients with T4 stage showed I-type tumor margins. Patients younger than 45 yr (n = 199) were excluded from this analysis because all were in stage I regardless of their T and N status. Of our 514 patients, 361 were diagnosed with PTMC. Observing the correlation between clinical or pathologic factors, and margin types of the patients with PTMC, we found significantly higher rates of tumor multiplicity (P = 0.015), extrathyroidal extension (P < 0.001), and coexistence of lymphocytic thyroiditis (P = 0.010) in patients with I-type than with E-type PTMCs (Table 2). The rate of metastasis to central or lateral neck lymph nodes was also higher in patients with I-type than with E-type PTMCs (36.4% vs 34.5%), but the difference was not significant. Among the 230 PTMC patients aged 45 yr or older, we also found a significant correlation between advanced stage and I-type margins (P < 0.001) (Table 2).
Table 2

Relationships between tumor margin type and clinicopathologic factors in patients with papillary thyroid microcarcinoma (PTMCs) (N = 361)

*Analysis among the PTMC patients aged 45 yr or older (n = 230); PTMC, papillary thyroid microcarcinoma; NS, not significant.

DISCUSSION

Papillary thyroid carcinoma usually has an excellent prognosis, and may be evaluated using various scoring systems. However, 5%-40% of PTC patients have persistent or recurrent disease, with progression and an unfavorable outcome (16, 17). Much effort has therefore been applied to identify and validate new prognostic criteria for PTC. Since the discovery that infiltrative margins indicate a poor prognosis in colorectal carcinoma, tumor margin histology has been interpreted to indicate tumor aggressiveness or invasiveness. Up to recently, the prognostic significance of this margin type has been approved from several studies in various malignancies (18-22). Including this one, all studies classified the margin types into two categories, (expanding vs infiltrative type) despite of variety of primary tumor; and the criteria for margin classification were also not much different. We thought this categorization was also most suitable and objective in PTC and tried to determine clean and concrete criteria to classify margin types. The significance of infiltrative margins in PTC was first reported in 1998 (23). That study with 134 patients found a positive association of an infiltrative margin with regional lymph node metastasis of PTC, which suggests that this pattern indicates aggressiveness. We found a strong correlation of the infiltrative margin with unfavorable prognostic factors including tumor multiplicity, extrathyroidal extension and lymph node metastasis. This correlation held also in PTMCs. There were also some differences between two margin types in patient age and rate of acompanying lymphocytic thyroiditis. We found a higher prevalence of coexistant lymphocytic thyroiditis in patients with I-type tumors than in those with the E-type. In this condition, circulating antibodies to thyroglobulin may prevent tumor spread; however, the prognostic significance of these antibodies, and of lymphocytic thyroiditis per se in PTC requires further study (7-11). And the mean age of patients with I-type tumor margins was lower than in those with the E-type (46.7 vs 49.4 yr). Although prognosis becomes less favorable with age, we did not assign importance to this result because 1) patients with both margin types were more than 45 yr old, and 2) among the patients aged 45 yr or older, significantly more of those with I-type than with E-type tumor margins showed advanced TNM stage (P < 0.001). Hence we concluded that the age difference between these two groups lacked clinical significance. In this study, we tested only the statistical relationship between tumor margin patterns and prognostic factors previously reported in patients with PTC. To our regret, since these patterns cannot be determined preoperatively, we cannot use them to plan the extent of surgery. However, the strong correlations between tumor margin histology and prognostic factors may inform postoperative treatment. Future studies using larger groups and longer follow-up period are needed to confirm these findings. Results from this study suggest that relationships between conventional risk factors and histologic patterns at tumor margins may be interpreted to predict tumor aggressiveness in patients with PTC.
  22 in total

Review 1.  Papillary and follicular thyroid carcinoma.

Authors:  M J Schlumberger
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

2.  Prognostic implications of the tall cell variant of papillary thyroid carcinoma.

Authors:  T L Johnson; R V Lloyd; N W Thompson; W H Beierwaltes; J C Sisson
Journal:  Am J Surg Pathol       Date:  1988-01       Impact factor: 6.394

3.  A new prognostic classification of rectal cancer.

Authors:  J R Jass; S B Love; J M Northover
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

4.  Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited.

Authors:  E Kebebew; P A Treseler; P H Ituarte; O H Clark
Journal:  World J Surg       Date:  2001-05       Impact factor: 3.352

5.  Natural history, treatment, and course of papillary thyroid carcinoma.

Authors:  L J DeGroot; E L Kaplan; M McCormick; F H Straus
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

6.  Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.

Authors:  B M Wenig; L D Thompson; C F Adair; B Shmookler; C S Heffess
Journal:  Cancer       Date:  1998-02-15       Impact factor: 6.860

7.  Infiltrating papillary thyroid carcinoma: review of 134 cases of papillary carcinoma.

Authors:  K T Mai; D G Perkins; H M Yazdi; A S Commons; J Thomas; S Meban
Journal:  Arch Pathol Lab Med       Date:  1998-02       Impact factor: 5.534

8.  Cancer statistics in Korea: incidence, mortality and survival in 2006-2007.

Authors:  Kyu-Won Jung; Sohee Park; Hyun-Joo Kong; Young-Joo Won; You-Kyung Boo; Hai-Rim Shin; Eun-Cheol Park; Jin-Soo Lee
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

9.  Prognostic value of the tall cell variety of papillary cancer of the thyroid.

Authors:  A Moreno Egea; J M Rodriguez Gonzalez; J Sola Perez; T Soria Cogollos; P Parrilla Paricio
Journal:  Eur J Surg Oncol       Date:  1993-12       Impact factor: 4.424

10.  Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients.

Authors:  E L Mazzaferri; R L Young
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

View more
  4 in total

1.  Prediction of cervical lymph node metastasis in patients with papillary thyroid cancer using combined conventional ultrasound, strain elastography, and acoustic radiation force impulse (ARFI) elastography.

Authors:  Jun-Mei Xu; Xiao-Hong Xu; Hui-Xiong Xu; Yi-Feng Zhang; Le-Hang Guo; Lin-Na Liu; Chang Liu; Xiao-Wan Bo; Shen Qu; Mingzhao Xing; Xiao-Long Li
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

Review 2.  The role of EMT and MET in cancer dissemination.

Authors:  Jacqueline Banyard; Diane R Bielenberg
Journal:  Connect Tissue Res       Date:  2015-08-20       Impact factor: 3.417

3.  Association Between Preoperative US, Elastography Features and Prognostic Factors of Papillary Thyroid Cancer With BRAFV600E Mutation.

Authors:  Jun-Mei Xu; Yong-Jun Chen; Yuan-Yuan Dang; Man Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-22       Impact factor: 5.555

4.  A Risk Model for Predicting Central Lymph Node Metastasis of Papillary Thyroid Microcarcinoma Including Conventional Ultrasound and Acoustic Radiation Force Impulse Elastography.

Authors:  Jun-Mei Xu; Hui-Xiong Xu; Xiao-Long Li; Xiao-Wan Bo; Xiao-Hong Xu; Yi-Feng Zhang; Le-Hang Guo; Lin-Na Liu; Shen Qu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.